Your browser doesn't support javascript.
loading
Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID).
Brugel, Mathias; Letrillart, Léa; Evrard, Camille; Thierry, Aurore; Tougeron, David; El Amrani, Mehdi; Piessen, Guillaume; Truant, Stéphanie; Turpin, Anthony; d'Engremont, Christelle; Roth, Gaël; Hautefeuille, Vincent; Regimbeau, Jean M; Williet, Nicolas; Schwarz, Lilian; Di Fiore, Frédéric; Borg, Christophe; Doussot, Alexandre; Lambert, Aurélien; Moulin, Valérie; Trelohan, Hélène; Bolliet, Marion; Topolscki, Amalia; Ayav, Ahmet; Lopez, Anthony; Botsen, Damien; Piardi, Tulio; Carlier, Claire; Bouché, Olivier.
Afiliação
  • Brugel M; University of Reims Champagne-Ardenne (URCA), Digestive Oncology and Hepatogastroenterology Department, CHU Reims, Reims, France. Electronic address: mbrugel@chu-reims.fr.
  • Letrillart L; University of Reims Champagne-Ardenne (URCA), Digestive Oncology and Hepatogastroenterology Department, CHU Reims, Reims, France.
  • Evrard C; Medical Oncology Department, CHU Poitiers, Poitiers, France.
  • Thierry A; Department of Research and Public Health, CHU Reims, Reims, France.
  • Tougeron D; University of Poitiers, Hepatogastroenterology Department, CHU Poitiers, Poitiers, France.
  • El Amrani M; Digestive Surgery and Liver Transplantation Department, CHRU Lille, CANTHER Laboratory Inserm UMR-S1277, University of Lille, Lille, France.
  • Piessen G; Digestive and Oncological Surgery Department, CHRU Lille, CANTHER Laboratory Inserm UMR-S1277, University of Lille, Lille, France.
  • Truant S; Digestive Surgery and Liver Transplantation Department, CHRU Lille, CANTHER Laboratory Inserm UMR-S1277, University of Lille, Lille, France.
  • Turpin A; Medical Oncology Department, CHRU Lille, CANTHER Laboratory Inserm UMR-S1277, University of Lille, Lille, France.
  • d'Engremont C; Digestive Oncology and Hepatogastroenterology Department, CHU Grenoble-Alpes, Grenoble-Alpes University, Grenoble, France.
  • Roth G; Digestive Oncology and Hepatogastroenterology Department, CHU Grenoble-Alpes, Grenoble-Alpes University, Grenoble, France.
  • Hautefeuille V; Digestive Oncology and Gastroenterology Department, CHU Amiens-Picardie, Amiens, France.
  • Regimbeau JM; Digestive Surgery Department, CHU Amiens-Picardie, SSPC (Simplification of Complex Patient Care) UR UPJV 7518, University of Picardie-Jules Verne, Amiens, France.
  • Williet N; Hepatogastroenterology Department, CHU Saint Etienne, Saint-Priest-en-Jarez, France.
  • Schwarz L; Digestive Surgery Department, CHU Rouen, UNIROUEN, Inserm 1245, IRON Group, Normandie University, Rouen, France.
  • Di Fiore F; Hepatogastroenterology Department, CHU Rouen, UNIROUEN, Inserm 1245, IRON Group, Normandie University, Rouen, France.
  • Borg C; Medical Oncology Department, CHU Besançon, INSERM, EFS BFC, UMR1098, RIGHT, University Bourgogne Franche-Comté, Besançon, France.
  • Doussot A; Digestive Surgical Oncology and Liver Transplantation Department, CHU Besançon, Besançon, France.
  • Lambert A; Medical Oncology Department, Lorraine Cancer Institute, Vandoeuvre-lès-Nancy, France.
  • Moulin V; Oncology Department, GH La Rochelle, La Rochelle, France.
  • Trelohan H; Oncology Department, GH La Rochelle, La Rochelle, France.
  • Bolliet M; Hepatogastroenterology Department, CH Colmar, Colmar, France.
  • Topolscki A; Hepatogastroenterology Department, CH Colmar, Colmar, France.
  • Ayav A; Hepatobiliary and Pancreatic Surgery Departement, CHRU Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.
  • Lopez A; Gastroenterology and Digestive Oncology, CHRU Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.
  • Botsen D; University of Reims Champagne-Ardenne (URCA), Digestive Oncology and Hepatogastroenterology Department, CHU Reims, Reims, France; Department of Medical Oncology, Godinot Cancer Institute, Reims, France.
  • Piardi T; General, Digestive and Endocrine Surgery Department, CHU Reims, Research Unit EA 3797 (VieFra) University of Reims Champagne-Ardenne (URCA), Reims, France.
  • Carlier C; University of Reims Champagne-Ardenne (URCA), Digestive Oncology and Hepatogastroenterology Department, CHU Reims, Reims, France; Department of Medical Oncology, Godinot Cancer Institute, Reims, France.
  • Bouché O; University of Reims Champagne-Ardenne (URCA), Digestive Oncology and Hepatogastroenterology Department, CHU Reims, Reims, France.
Eur J Cancer ; 166: 8-20, 2022 05.
Article em En | MEDLINE | ID: mdl-35259629
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article